A.J. Kazimi 13D and 13G filings for Cumberland Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 5:12 pm Purchase | 2026-01-30 | 13G | Cumberland Pharmaceuticals Inc. CPIX | A.J. Kazimi | 5,789,155 38.400% | 86,859 (+1.52%) | Filing |
| 2025-02-13 5:26 pm Sale | 2025-02-13 | 13G | Cumberland Pharmaceuticals Inc. CPIX | A.J. Kazimi | 5,702,296 40.800% | -51,062 (-0.89%) | Filing |
| 2023-02-10 5:01 pm Sale | 2022-12-31 | 13G | Cumberland Pharmaceuticals Inc. CPIX | A.J. Kazimi | 5,753,358 39.410% | -17,205 (-0.30%) | Filing |
| 2022-02-14 5:17 pm Purchase | 2021-12-31 | 13G | Cumberland Pharmaceuticals Inc. CPIX | A.J. Kazimi | 5,770,563 38.330% | 227,218 (+4.10%) | Filing |